Showing results (141-150 of 309) with videos related to

Sort By:
Pageof 31
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with AtezolizumabEugene Tan, Ahmad Y Abuhelwa, Sarah Badaoui, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-AnalysisJons W van Hattum, Ben Max de Ruiter, Jorg R Oddens, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder CancerAvani Desai, Lucas Bouknight, Thomas Reed, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
The Evolution of Nadofaragene Firadenovec: A Review and the Path ForwardAlexis R Steinmetz, Sharada Mokkapati, David McConkey, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancerErnest Kaufmann, Stefanie Aeppli, Andres Affentranger, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 26, 2026
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patientsSarafina Urenna Otis, Aruni Ghose, Giuseppe Luigi Banna, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 27, 2026
Proceedings of the first international NMIBC consensus classification meetingJoep J de Jong, Ane Moreno-Oya, Mitchell Olislagers, et al.
Pageof 31